Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis
Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses.
Complementary and Alternative Medicine Use and Nutrient Intake Among Individuals with Multiple Sclerosis in the United States.
Patients' experiences of adapting to multiple sclerosis: a qualitative study.
Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis (EAE) Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge.
Fatigue and Depression in Children With Demyelinating Disorders.
Impact of Cigarette Smoking on Conversion from Clinically Isolated Syndrome to Clinically Definite Multiple Sclerosis.
Suppression of Experimental Autoimmune Optic Neuritis by the Novel Agent Fingolimod.
Secukinumab (AIN457) showed superiority over Enbrel® in clearing skin, according to pivotal Novartis Phase III psoriasis results at EADV
Enhanced myelination in autoimmunity and in normal development induced by glatiramer acetate.
Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios.
The immune balance between memory and regulatory B cells in NMO and the changes of the balance after methylprednisolone or rituximab therapy.
CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation.
Caffeine and alcohol intakes have no association with risk of multiple sclerosis.
Fingolimod increases brain-derived neurotrophic factor levels and ameliorates amyloid β-induced memory impairment.
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease.
The risk of smoking on multiple sclerosis: a meta-analysis based on 20,626 cases from case-control and cohort studies.
Association between pathological and MRI findings in multiple sclerosis.
A CB(1)/CB(2) receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin.
Estimated incidence of multiple sclerosis among United States Armed Forces personnel using the Defense Medical Surveillance System.
Transcriptional profiling of microdissected areas of active multiple sclerosis lesions reveals activation of heat shock protein genes.
A Randomized Controlled Trial of Cognitive Behavioral Therapy (CBT) for Adjusting to Multiple Sclerosis (the saMS Trial): Does CBT Work and for Whom Does It Work?
Natalizumab discontinuation and disease restart in pregnancy: a case series.
Psychiatric disorders in patients with multiple sclerosis.
Could Intrathymic Injection of Myelin Basic Protein Suppress Inflammatory Response After Co-culture of T Lymphocytes and BV-2 Microglia Cells?

Pages